Format

Send to

Choose Destination
See comment in PubMed Commons below
Surv Ophthalmol. 2002 Jan-Feb;47(1):63-73.

Primary drug treatment for glaucoma: beta-blockers versus other medications.

Author information

1
Department of Ophthalmology, University of California, San Francisco, CA, USA.

Abstract

This set of Viewpoints articles examines the merits of beta-blockers versus other medications as the primary drug treatment for glaucoma. Ophthalmologists must balance issues such as efficacy, compliance, cost, and side effects when deciding on the appropriate medication to prescribe. Dr. Stamper stresses the advantages of tailoring the choice of medication to the needs of the individual patient. Drs. Wigginton and Higginbotham review the benefits of beta-blockers and present some of the disadvantages of the non-beta-blocker class of medications.

PMID:
11801272
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center